Clinical approach and diagnosis of membranoproliferative glomerulonephritis, case report
PDF (Español)
HTML (Español)

Keywords

Nephrotic Syndrome, Glomerulonephritis, Membranoproliferative Glomerulonephritis, Proteinuria, Complement Activation, Acute Kidney Injury.

How to Cite

1.
Torres Serrano RE, Rosselli Sanmartín C, Olivares Algarín O, Olivares Algarín CR, Latorre Núñez Y, Moreno Lucero PA, Zambrano Amastha LC, Ardila Castillo W. Clinical approach and diagnosis of membranoproliferative glomerulonephritis, case report. Rev. Colomb. Nefrol. [Internet]. 2020 Oct. 20 [cited 2024 Jul. 15];7(2). Available from: https://revistanefrologia.org/index.php/rcn/article/view/366

Abstract

The membranophroliferative glomerulonephritis is a rare lesion that covers a group of pathologies that share a histologic pattern, and can generate from diverse pathogenic mechanisms. Based on the findings of the kidney biopsy, starts a process to search the etiology of the lesion. The initial kidney damage occurs due to the deposit of immunoglobulins, complement elements or both in the mesangium and in the capillary endothelium, generating sub endothelial, sub epithelial, and/or glomerular basal membrane deposits, frequently adopting glomerulus a lobed aspect. We present a case of a man 48 years old admitted in the emergency of the San Jose Hospital in Bogotá, without relevant pathological background that debuts with proteinuria in severe nephrotic range (62 grams in 24 hours), nitrogenous elevation and biopsy report with membranophroliferative glomerulonephritis, we describe de clinical and diagnostic approach of this entity.

https://doi.org/10.22265/acnef.7.2.366
PDF (Español)
HTML (Español)

References

Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, et al. Changing incidence of glomerular disease in

Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006;1(3):483-7.

https://dx.doi.org/10.2215/CJN.00710805.

Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Distribution of primary renal diseases leading to end-

stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J

Kidney Dis. 2000;35(1):157-65. https://dx.doi.org/10.1016/S0272-6386(00)70316-7.

KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl. 2012 [citado octubre 23 2020];2(2). Available from:

http://www.nature.com/kisup/journal/v2/n2/index.html.

Briganti EM, Dowling J, Finlay M, Hill PA, Jones CL, Kincaid-Smith PS, et al. The incidence of biopsy-proven glomerulonephritis in

Australia. Nephrol Dial Transplant. 2001;16(7):1364-7. https://dx.doi.org/10.1093/ndt/16.7.1364.

Sethi S, Fervenza FC. Membranoproliferative Glomerulonephritis-A New Look at an Old Entity. N Engl J Med. 2012;366(12):1119-

https://dx.doi.org/10.1056/NEJMra1108178.

Sethi S, Gamez JD, Vrana JA, Theis JD, Bergen HR 3rd, Zipfel PF, et al. Glomeruli of dense deposit disease contain components of the

alternative and terminal complement pathway. Kidney Int. 2009;75(9):952-60. https://dx.doi.org/10.1038/ki.2008.657.

Masani N, Jhaveri KD, Fishbane S. Update on Membranoproliferative GN. Clin J Am Soc Nephrol. 2014;9(3):600-8.

https://dx.doi.org/10.2215/CJN.06410613.

González L, Cantillo J. Abordaje diagnóstico de la enfermedad glomerular del adulto. Transformando una idea compleja en un proceso

práctico. Acta Med Colomb. 2013;38(2):101-7.

Zand L, Fervenza FC, Nasr SH, Sethi S. Membranoproliferative glomerulonephritis associated with autoimmune diseases. J Nephrol.

;27(2):165-71. https://dx.doi.org/10.1007/s40620-014-0049-0.

Sethi S, Zand L, Leung N, Smith RJ, Jevremonic D, Herrmann SS, et al. Membranoproliferative Glomerulonephritis Secondary to

Monoclonal Gammopathy. Clin J Am Soc Nephrol. 2010;5(5):770-82. https://dx.doi.org/10.2215/CJN.06760909.

Hogan JJ, Alexander MA, Leung N. Dysproteinemia and the Kidney: Core Curriculum 2019. Am J Kidney Dis. 2019;74(6):822-36.

https://dx.doi.org/10.1053/j.ajkd.2019.04.029.

Galle P, Mahieu P. Electron dense alteration of kidney basement membranes. A renal lesion specific of a systemic disease. Am J Med.

;58(6):749-64. https://doi.org/10.1016/0002-9343(75)90631-2.

Salvadori M. Rosso G. Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN. World J

Nephrol. 2016;5(4):308-20. https://dx.doi.org/10.5527/wjn.v5.i4.308.

Meri S, Koistinen V, Miettinen A, Törnroth T, Seppälä IJ. Activation of the alternative pathway of complement by monoclonal lambda

light chains in membranoproliferative glomerulonephritis. J Exp Med. 1992;175(4):939-50. https://dx.doi.org/10.1084/jem.175.4.939.

Bridoux F, Desport E, Frémeaux-Bacchi V, Chong CF, Gombert JM, Lacombe C, et al. Glomerulonephritis with isolated C3 deposits and

monoclonal gammopathy: a fortuitous association? Clin J Am Soc Nephrol. 2011;6(9):2165-74.

https://dx.doi.org/10.2215/CJN.06180710.

Sethi S, Nester CM, Smith RJH. Membranoproliferative glomerulonephritis and C3 glomerulopath: resolving the confusion. Kidney

Int. 2012;81(5):434-41. https://dx.doi.org/10.1038/ki.2011.399.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Revista Colombiana de Nefrología

Dimensions


PlumX


Downloads

Download data is not yet available.